|
Volumn 429, Issue 1-3, 2001, Pages 121-125
|
Neuropathic pain in Anderson-Fabry disease: Pathology and therapeutic options
|
Author keywords
Galactosidase A; Anderson Fabry disease; Fabry's disease; Neuropathic pain
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA GALACTOSIDASE;
AMITRIPTYLINE;
CARBAMAZEPINE;
CODEINE;
GLOBOTRIAOSYLCERAMIDE;
MORPHINE;
NEUROTROPIN;
OPIATE;
PARACETAMOL;
PHENYTOIN;
SODIUM CHANNEL BLOCKING AGENT;
AUTONOMIC NEUROPATHY;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE ASSOCIATION;
DISEASE COURSE;
ENZYME DEFICIENCY;
ENZYME REPLACEMENT;
FABRY DISEASE;
GENE THERAPY;
HUMAN;
LIPID STORAGE;
MULTIPLE ORGAN FAILURE;
NEUROPATHOLOGY;
NEUROTRANSMISSION;
PAIN;
PATHOPHYSIOLOGY;
PLASMAPHERESIS;
PRIORITY JOURNAL;
REVIEW;
SPINAL GANGLION;
TREATMENT OUTCOME;
VASOCONSTRICTION;
VASODILATATION;
CLINICAL TRIALS;
FABRY DISEASE;
HUMANS;
MONONEUROPATHIES;
PAIN;
POLYNEUROPATHIES;
|
EID: 0035840844
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01312-7 Document Type: Review |
Times cited : (53)
|
References (25)
|